Zárate-Mondragón FE, Casas-Guzik L, Ayala-Germán AG

Idioma: Español
Referencias bibliográficas: 23
Paginas: 260-267
Archivo PDF: 269.41 Kb.

FRAGMENTO

Definición

La ictericia (coloración amarillenta de la piel y las mucosas), resulta de la acumulación de pigmentos biliares, con concentración de bilirrubina total mayor de 2. mg/dL. El síndrome colestásico es la elevación de bilirrubina directa mayor de 1 mg/dL (17 mmol/L), cuando la bilirrubina total es menor de 5 mg/dL o bilirrubina directa mayor de 20%, si la bilirrubina total es mayor de 5 mg/dL.1-3 Cuando persiste más de dos semanas, en los primeros tres meses de vida, se denomina síndrome colestásico neonatal prolongado

REFERENCIAS (EN ESTE ARTÍCULO)

1. Andrianov MG, Azzam RK. Cholestasis in infancy. Pediatr Ann. 2016; 45 (12): e414-9. doi: 10.3928/19382359-20161118-01

2. Fawaz R, Baumann U, Ekong U, Fischler B, et al. Guideline for the evaluation of cholestatic jaundice in infants: Joint recommendations of the North American society for pediatric gastroenterology, hepatology, and nutrition and the European society for pediatric gastroenterology, hepatology, and nutrition. J Pediatr Gastroenterol Nutr. 2017; 64 (1): 154-68. doi: 10.1097/MPG.0000000000001334

3. Pandita A, Gupta V, Gupta G. Neonatal Cholestasis: A Pandora’s Box. Clinical Medicine Insights: Pediatrics. 2018; 12: 1-6. doi: 10.1177/1179556518805412

4. Corcuera CT, Ridaura C, Zárate FE. Atresia biliar perinatal (colangiopatía obliterante inflamatoria progre siva) no corregible tipo III. Acta Pediatr Mex. 2018; 39 (4): 328-37. DOI: http://dx.doi.org/10.18233/APM- 39No4pp328-3371642

5. Khalaf R, Phen C, Karjoo S, Wilsey M. Cholestasis beyond the neonatal and infancy periods. Pediatr Gastroenterol Hepatol Nutr. 2016; 19 (1): 1-11. doi: 10.5223/ pghn.2016.19.1.1

6. Lane E, Murray KF. Neonatal Cholestasis. Pediatr Clin North Am. 2017; 64 (3): 621-39. doi: 10.1016/j.pcl.2017.01.006

7. Feldman AG, Sokol RJ. Neonatal cholestasis: emerging molecular diagnostics and potential novel therapeutics. Nat Rev Gastroenterol Hepatol 2019; 16 (6): 346-60. doi: 10.1038/s41575-019-0132-z

8. Matsui A. Screening for biliary atresia. Pediatr Surg Int. 2017; 33 (12): 1305-13. doi: 10.1007/s00383-017-4175-3

9. Reyes A, Flores J, Villasis M, Chávez JA, Delgado EE. Uso de la tarjeta colorimétrica visual para la detección oportuna de atresia de vías biliares. Bol Med Hosp Infant Mex. 2018; 75 (3): 160-5. https://doi.org/10.24875/bmhim. m18000023

10. Ghoshal B, Das A, Mondal T. A Rare Case of Neonatal Cholestasis. J Clin Neonatol 2017; 6: 34-6. doi: 10.4103/2249- 4847.199759

11. Girard M, Lacaille F. Diagnosis of Neonatal Cholestasis. Ann Nestlé. 2008; 66: 109-20. https://doi. org/10.1159/000147408

12. Jagadisan B, Srivastava A. Child with Jaundice and Pruritus: How to Evaluate? Indian J Pediatr. 2016; 83 (11): 1311-20. doi: 10.1007/s12098-016-2058-6

13. Vázquez R, García JE, Valencia PF, Castro GE, et al. Mexican consensus on lysosomal acid lipase deficiency diagnosis. Rev Gastroenterol México. 2018; 83 (1): 51-61. doi: 10.1016/j.rgmx.2017.08.001

14. Karpen SJ. Pediatric Cholestasis: Epidemiology, Genetics, Diagnosis, and Current Management. Clin Liver Dis. 2020; 15 (3): 115-19. doi: 10.1002/cld.895

15. Abbey P, Devasenathipathy K, Naranje P. Neonatal Jaundice. Indian J Pediatr. 2019; 86: 830-41. doi: 10.1007/s12098- 019-02856-0

16. Mitchell E, Gilbert M, Loomes KM. Alagille Syndrome. Clin Liver Dis. 2018; 22 (4): 625-41. doi: 10.1016/j. cld.2018.06.001

17. Cho SJ, Kim GE. A practical approach to the pathology of neonatal cholestatic liver disease. Semin Diagn Pathol. 2019; 36 (6): 375–88 doi: 10.1053/j.semdp.2019.07.004

18. Ridaura C. La biopsia hepática. Acta Pediatr Mex. 2008; 29 (4): 216-26. https://ojs.actapediatrica.org.mx/index.php/ APM/article/viewFile/267/267

19. Orso G, Mandato C, Veropalumbo C. Pediatric parenteral nutrition-associated liver disease and cholestasis: Novel advances in pathomechanisms-based prevention and treatment. Digestive and Liver Disease. 2016; 48: 215-22. doi: 10.1016/j.dld.2015.11.003

20. Sullivan JS, Mascarenhas MR. Nutrition: Prevention and management of nutritional failure in Cystic Fibrosis. J Cyst Fibros. 2017; 16: 87-93. doi: 10.1016/j.jcf.2017.07.010

21. Whitington PF. Gestational Alloimmune Liver Disease And Neonatal Hemochromatosis. Semin Liver Dis. 2012; 32: 325-32. doi: 10.1055/s-0032-1329901

22. Heubi JE, Setchell KDR, Bove KE. Inborn Errors of Bile Acid Metabolism. Clin Liver Dis. 2018; 22 (4): 671-87. doi: 10.1016/j.cld.2018.06.006

23. Dursun F, Gerenli N, Kirmizibekmez H. Cholestasis and hypercalcemia secondary to panhypopituitarism in a newborn. Turkish J Pediatr. 2017; 59: 100-3. doi: 10.24953/ turkjped.2017.01.020